• GW4064: Non-Steroidal FXR Agonist Workflows in Metabolic Res

  2026-05-15

  GW4064 stands out as a potent, selective non-steroidal FXR agonist optimized for dissecting bile acid and lipid metabolism, as well as advanced fibrosis pathways. This guide distills the latest experimental protocols, troubleshooting strategies, and key innovations—empowering metabolic researchers to achieve robust, reproducible FXR activation.

• Tirbanibulin Suppresses HPV Oncoproteins via Src-MEK Pathway

  2026-05-14

  This study demonstrates that tirbanibulin significantly inhibits cell proliferation and downregulates key oncogenic proteins, including HPV E6/E7, in HPV-18+ HeLa cells by targeting the Src-MEK signaling axis. The findings clarify tirbanibulin's mechanism in HPV-associated cancer models and provide a robust foundation for translational research targeting post-translational regulation in oncogenesis.

• Resiniferatoxin as a Precision Tool for TRPV1-Positive Affer

  2026-05-14

  The reviewed study highlights resiniferatoxin (RTX) as an ultra-potent, selective TRPV1 agonist with a unique ability to chemically inactivate sensory neurons, enabling targeted analgesia without unacceptable side effects. This work clarifies RTX’s mechanistic specificity, therapeutic window, and translational relevance for neuropathic and osteoarthritis pain, as well as emerging clinical applications.

• WEHI-539 in Synthetic Lethality: Advanced BCL-XL Inhibition

  2026-05-13

  Explore how WEHI-539, a potent BCL-XL inhibitor, enables synthetic lethality and advanced apoptosis research. This article offers a unique deep-dive into practical assay decisions and translational strategies that surpass standard methodologies.

• Aztreonam: Applied Workflows Against Gram-Negative Bacteria

  2026-05-13

  Aztreonam, a monocyclic β-lactam antibiotic, offers targeted inhibition of Gram-negative aerobic bacteria with high solubility and stability in research-grade applications. This article delivers stepwise protocols, troubleshooting strategies, and experimental insights leveraging APExBIO’s Aztreonam, translating cutting-edge resistance data into pragmatic assay choices.

• Viral Targeting of RIPK3: Mechanisms Regulating Necroptosis

  2026-05-12

  This study uncovers how orthopoxviruses deploy a viral inducer of RIPK3 degradation (vIRD) to subvert host necroptosis and regulate virus-induced inflammation. These mechanistic insights reveal new connections between viral evasion strategies, ubiquitin-mediated protein degradation, and host immune responses, informing translational approaches in inflammation and antiviral research.

• iPSC-Based Drug Prescreening for Ultrarare Disease Patients

  2026-05-12

  This study introduces a patient-specific induced pluripotent stem cell (iPSC) platform for prescreening drug efficacy in individuals with ultrarare genetic variants, demonstrated through an 18-year-old with Leigh-like syndrome. The platform enabled personalized drug selection, improving metabolic outcomes and offering a model for precision medicine in undiagnosed or poorly characterized diseases.

• Dabigatran Etexilate: Oral Anticoagulant Innovation and CYP3

  2026-05-11

  The referenced clinical review highlights dabigatran etexilate as the first oral direct thrombin inhibitor with predictable pharmacokinetics, rapid onset, and independence from CYP3A-mediated metabolism. These properties address limitations of traditional anticoagulants and have significant implications for drug-drug interaction research and study design.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Use

  2026-05-11

  The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) provides researchers with a rapid, quantitative method for assessing SOD enzyme activity in biological samples, supporting studies of oxidative stress and antioxidative defense. It is intended for laboratory research use only and should not be used for diagnostic or clinical purposes. Researchers working outside of oxidative stress or redox biology contexts may find limited applicability.

• Dicoumarol Inhibits IRE1α to Mitigate ER Stress-Induced Live

  2026-05-10

  This study identifies dicoumarol as a novel inhibitor of IRE1α activity, alleviating ER stress-induced acute liver injury in mouse models. The findings showcase an integrated screening strategy and highlight critical mechanisms by which targeting the IRE1α-XBP1 branch of the unfolded protein response can protect hepatic tissue.

• Fucoidan (C4038): Anticancer Sulfated Polysaccharide Benchma

  2026-05-09

  Fucoidan, a sulfated α-L-Fucan from brown seaweed, exhibits robust anticancer and immune-modulating effects. Recent data confirm its ability to selectively inhibit breast cancer cell proliferation and suppress metastasis through distinct molecular pathways.

• Y-27632 Dihydrochloride: Applied Workflows for ROCK Inhibiti

  2026-05-09

  Y-27632 dihydrochloride, a highly selective ROCK inhibitor from APExBIO, enables robust stem cell viability and precise modulation of cytoskeletal dynamics. This guide delivers experimental blueprints, advanced troubleshooting, and practical insights rooted in cutting-edge research for unlocking the full potential of Y-27632 in cancer and neurodevelopmental studies.

• hiPSC-Derived Intestinal Organoids in Pharmacokinetic Modeli

  2026-05-08

  This study presents a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids (IOs) with robust differentiation capacity and long-term propagation. The resulting IO-derived intestinal epithelial cells demonstrate mature transporter and metabolic enzyme activities, providing a physiologically relevant human model for pharmacokinetic studies and anti-inflammatory drug research.

• Methicillin Sodium Salt: Precision Tools for MSSA Research

  2026-05-07

  Methicillin sodium salt remains the gold standard for benchmarking anti-staphylococcal assays, offering robust, reproducible inhibition of bacterial cell wall synthesis in MSSA models. APExBIO’s high-purity formulation empowers researchers with reliable, quantifiable performance for susceptibility testing and resistance profiling.

• Difloxacin HCl: Deep Dive Into Mechanisms and Research Front

  2026-05-07

  Explore the advanced mechanisms of Difloxacin HCl, a quinolone antimicrobial antibiotic, and its emerging research applications in multidrug resistance and cell cycle regulation. This article delivers unique, actionable insights not found in standard reviews.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page